BPI Recombinant Antibody, Cy5 Conjugated
Product Specifications
Background
The cytotoxic action of BPI is limited to many species of Gram-negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa.
Synonyms
RBPI; BPIFD1; CAP 57; BPI; Bactericidal permeability-increasing protein.
Gene ID
671
Swiss Prot
P17213
Cellular Locus
Cytoplasm, Secreted, Cell membrane
Host
Rabbit
Cross Reactivity
Human
Target
BPI
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human BPI
Applications
WB, Flow-Cyt
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
Lot dependent
Dilution
WB (1:300-5000), Flow-Cyt (1ug/Test)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
671
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B686920-250MG 250 mg
2-(3-Bromopropyl)-1,2,4-triazolo-pyridin-3-one
Sign In for Pricing
View Details 
